(Q43608961)

25 November 2017

title

Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals (English)

1 reference

left ventricular hypertrophy

25 November 2017

main subject

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

A Mantovani

1

1 reference

25 November 2017

G Zoppini

2

1 reference

25 November 2017

G Targher

3

1 reference

25 November 2017

G Golia

4

1 reference

25 November 2017

E Bonora

5

1 reference

25 November 2017

publication date

1 February 2012

1 reference

Journal of Endocrinological Investigation

25 November 2017

published in

1 reference

25 November 2017

volume

35

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

215-218

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03345421

25 November 2017

exact match

0 references

cites work

Non-alcoholic fatty liver disease: the mist gradually clears

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Obesity-associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Assessing kidney function--measured and estimated glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Left ventricular hypertrophy and clinical outcomes in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Insulin resistance in patients with cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Insulin resistance syndrome and left ventricular mass in healthy young people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Relationship between plasma insulin and left ventricular mass in normotensive participants of the Gubbio Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Relationship of Insulin Sensitivity and Left Ventricular Mass in Uncomplicated Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Non-invasive means of measuring hepatic fat content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Prediction of Mortality Risk by Different Methods of Indexation for Left Ventricular Mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345421

Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease

21 January 2018

1 reference

12 December 2020

Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects

1 reference

12 December 2020

Insulin resistance is an important determinant of left ventricular mass in the obese

1 reference

12 December 2020

The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis

1 reference

12 December 2020

Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Liver pathology and the metabolic syndrome X in severe obesity.

1 reference

12 December 2020

Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment

1 reference

12 December 2020

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345421

1 reference

Dimensions Publication ID

25 November 2017

1025757320

0 references

1 reference